Widely debated IVF add-on does not increase clinical pregnancy rates, according to new retrospective research.

Genome editing reactivates an embryonic gene to help compensate for missing alpha-globin in preclinical research into alpha-thalassaemia.

An AI model could help estimate the risk of miscarriage after IVF, using data routinely collected during treatment.

Participants in a national engagement programme have expressed support for using genomics to help prevent illness and personalise healthcare, while emphasising that its wider use must be underpinned ...

Prime editing – a type of genome editing – has been used to alter DNA directly inside a person's body for the first time... Prime editing – a type of genome editing – has been used to alter DNA ...

Guy Davies, third prize winner in this year's Marcus Pembrey BioNews Writing Competition, explores what happens when AI starts to define what makes an embryo the 'best'. What are the promises and ...

Parental age and various procedures used during assisted reproductive technology have been linked to different patterns of mutational changes in the DNA of offspring... Parental age and various ...

An Irish television programme has brought the selling of IVF add-ons to public attention. The documentary 'Fertility Uncovered' included footage from the Future Fertility Show in Dublin, an event ...

Dr Andrea Martani discusses age cutoffs for IVF and fertility treatment: are they based on medical evidence or societal norms?... In July 2026, PET and ESHRE published a joint report containing the ...

Spending time outside without sun protection is often believed to be safe if it takes place early or late at day, when the sun is less strong. A new study published in Photochemistry and Photobiology ...

From light-sensitive, single-celled algae to using lasers to trigger mouse whisker movements, the 2026 Nobel Prize in Physiology or Medicine recognises the discovery of light-gated ion channels and ...

A gene therapy for Huntington's disease failed to show statistically significant slowing of disease progression after 48 months, according to newly released data... A gene therapy for Huntington's ...